本页面由Tiger Trade Technology Pte. Ltd.提供服务

Benitec Biopharma Limited

8.63
-0.4400-4.85%
盘后:8.630.00000.00%19:30 EDT
成交量:15.14万
成交额:131.40万
市值:3.01亿
市盈率:-8.82
高:9.08
开:9.08
低:8.51
收:9.07
52周最高:16.76
52周最低:8.51
股本:3,488.27万
流通股本:1,845.34万
量比:0.83
换手率:0.82%
股息:- -
股息率:- -
每股收益(TTM):-0.9783
每股收益(LYR):-0.9800
净资产收益率:-33.21%
总资产收益率:-22.67%
市净率:1.70
市盈率(LYR):-8.81

数据加载中...

2021/12/21

重要事件披露

8-K - Current report
2021/12/13

重要事件披露

8-K - Current report
2021/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/29

重要事件披露

8-K - Current report
2021/04/28

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/28

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/27

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/04/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/22

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/24

重要事件披露

8-K - Current report
2021/02/18

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/19

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals